Cervical spondylotic myelopathy
Conditions
Interventions
Control group:None
Observation group:None
Sponsors
The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria of cervical spondylotic myelopathy; 2. Age of 18-60 years old, both sexes, stable vital signs; 3. Course of disease > 3 months; 4. Voluntarily accept the corresponding treatment plan (the observation group underwent dynamic MRI before surgery, and the control group underwent conventional MRI before surgery); 5. No history of glucocorticoid use 4 weeks before treatment; 6. Signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients who did not meet the diagnostic criteria of cervical spondylotic myelopathy in the medical record, or whose baseline data (course of disease, imaging report, symptom record) were incomplete, and the efficacy and safety evaluation could not be completed; 2. Medical records showed that they had participated in other clinical studies in the past 3 months, with intervention crossover or data interference possible; 3. patients with a history of severe cervical spine trauma, cervical spine surgery or other spine-related surgery (based on operation records and hospitalization history), which may affect the comparability of surgical programs and efficacy evaluation; 4. patients with serious underlying diseases such as heart, liver, kidney or other important organ dysfunction, hematopoietic dysfunction or malignant tumors, which may increase the study bias or affect the follow-up outcome; 5. patients with a history of dependence on opioids, sedatives and hypnotics or long-term alcohol abuse (based on the medication record or self-history), which may interfere with the assessment of neurological function; 6. pregnant or lactating women (based on obstetric history and examination records); 7. The use of glucocorticoids in the medical records for 4 weeks before treatment, which may affect the evaluation of neurological function or inflammatory response and interfere with the evaluation of efficacy;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recovery Rate of modified Japanese Orthopaedic Association score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale Score;Neck Disability Index; | — |
Countries
China
Contacts
Public ContactZhongYuanming
The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine
Outcome results
None listed